Skip to content
← Back to this collection

PUBLICATIONS · 9129042

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
1997 May 1
First author
Shen ZX

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Shen ZX
      type
      Author
    2. name
      Chen GQ
      type
      Author
    3. name
      Ni JH
      type
      Author
    4. name
      Li XS
      type
      Author
    5. name
      Xiong SM
      type
      Author
    6. name
      Qiu QY
      type
      Author
    7. name
      Zhu J
      type
      Author
    8. name
      Tang W
      type
      Author
    9. name
      Sun GL
      type
      Author
    10. name
      Yang KQ
      type
      Author
    11. name
      Chen Y
      type
      Author
    12. name
      Zhou L
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Shen ZX
      type
      Author
    2. name
      Chen GQ
      type
      Author
    3. name
      Ni JH
      type
      Author
    4. name
      Li XS
      type
      Author
    5. name
      Xiong SM
      type
      Author
    6. name
      Qiu QY
      type
      Author
    7. name
      Zhu J
      type
      Author
    8. name
      Tang W
      type
      Author
    9. name
      Sun GL
      type
      Author
    10. name
      Yang KQ
      type
      Author
    11. name
      Chen Y
      type
      Author
    12. name
      Zhou L
      type
      Author
    bibliography ids
    1. nci-bib-e0bafd244b716d2c6234aa2a
    book metadata
    content sha256
    9fecb447d5c9ea5f1f5ab13444ff7ddc896699422926dc81f88472fdcb5e0901
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:9129042
      immutable id
      pubmed:9129042@9fecb447d5c9ea5f1f5ab13444ff7ddc896699422926dc81f88472fdcb5e0901
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      9
      name
      Blood
      nlm unique id
      7603509
      pages
      3354-60
      volume
      89
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        9129042
        provenance
        batch id
        629590480cca3a097fa8
        provider
        NCBI PubMed ESummary
        record sha256
        a33fa9b7d60be4baaaf6750ac5a77d53398c0390c117fbac7d57c75ce880c02b
        response sha256
        0eb1cec7011436204408643f1cea7888e97d436038d0a09eaecfd9b32db84919
        retrieved at
        2026-09-09T23:45:26.993225+00:00
        publication date
        display
        1997 May 1
        precision
        day
        year
        1997
        publication types
        1. Clinical Trial
        2. Journal Article
        3. Multicenter Study
        4. Research Support, Non-U.S. Gov't
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/9129042/
        title
        Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.

        Preserved source evidence · Not medical advice